ArticleAntioxidants (Basel, Switzerland)2025
Antibacterial Properties, Arabinogalactan Proteins, and Bioactivities of New Zealand Honey.
Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuro-protective Potential of Honey: A Narrative Review.Current pharmaceutical design · 2026Review
- Synthesis, Characterization, Antioxidant Activity, Antibacterial Activity, and Cytotoxicity of Quaternized Inulin Derivatives Bearing Aromatic Amides.Antioxidants (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Honey has been used for centuries for its antibacterial and healing properties. The aim of this study was to investigate the antibacterial properties, arabinogalactan proteins (AGPs), antioxidant activities, and polyphenolic content of eight different types of New Zealand honey (clover, mānuka, beech honeydew, pōhutukawa, kānuka, rewarewa, kāmahi and thyme honey). The results showed varying antibacterial activities across the honey types, with mānuka, pōhutukawa, and kāmahi honey exhibiting significant inhibitory effects. Interestingly, all honey samples demonstrated inhibitory effects on bacterial growth at 25% concentration. Furthermore, AGPs were found in all eight honey samples, with higher amounts in kānuka, kāmahi, pōhutukawa, mānuka, and rewarewa honey. Thyme had the highest antioxidant values in terms of CUPRAC, FRAP and DPPH, while kāmahi honey had the lowest antioxidant value. Beech honeydew honey had the highest Total Flavonoid Content (TFC) values, while thyme and clover honey had the lowest TFC values. Similarly, thyme honey exhibited the highest Total Phenolic Content (TPC) value, with kāmahi and clover honey having the lowest TPC values. Furthermore, only thyme and beech honeydew New Zealand honeys contained vitamin C. The different honeys contained varying concentrations of polyphenols, with mānuka, kānuka, and pōhutukawa honeys having high amounts of quercetin, luteolin, and gallic acid, respectively. In contrast, clover honey had notable levels of chrysin, pinocembrin, caffeic acid, and pinobanksin. Overall, this study provides valuable insights into the antibacterial properties and bioactivities of native New Zealand honeys, contributing to our understanding of the potential health benefits associated with these honeys and their potential use as natural alternatives to improve human health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.